Acknowledgments
Competing interests : Harald Vonkeman has received honorariums
from UCB, Novartis, Boehringer, Galapagos and Pfizer. Harald Vonkeman is
a board member of the Dutch Arthritis Society. Naomi Jessurun is a board
member Dutch Royal Society of Pharmacists. All other authors confirm
that they have no competing interests to declare.
Funding: This research received no specific grant from any funding
agency in the public, commercial or not-for-profit sectors.
Data availability statement: The datasets generated and
analyzed for the current study are not publicly available due to legal
restrictions related to data privacy protection but are available from
the corresponding author on reasonable request.